Diffuse large B-cell lymphoma: open trials in Croatia

3 open trials have a site in Croatia. Registry data; only the trial team decides who can take part.

2025-524230-25-00
HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before
Trial Treatment · Phase 2 · Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Clinical Hospital Dubrava, Grad Zagreb · Klinicki bolnicki centar Sestre milosrdnice, Grad Zagreb · KBC Split, Split · University Hospital Centre Zagreb, Zagreb · Klinicka bolnica Merkur, Zagreb
Registry updated 2026-10-27
NCT04792489
DALY II USA/ MB-CART2019.1 for DLBCL
Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH
KBC Zagreb, Grad Zagreb
Registry updated 2026-07-13
NCT04844866
Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients
Trial Treatment · Phase 2 · Miltenyi Biomedicine GmbH
University Hospital Centre Zagreb, Zagreb
Registry updated 2026-06-10

This page is not medical advice. Talk to your doctor before contacting a trial.

HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before